| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interferon beta 1 | 0.421 | 0.846 |
|
disease | 0.400 | None | 0.958 | 308 | 0 | 1995 | 2020 | |||||||||
|
myelin basic protein | 0.510 | 0.885 | 0.28 |
|
disease | 0.100 | None | 0.939 | 163 | 0 | 1990 | 2020 | ||||||||
|
multiple sclerosis | 0.599 | 0.692 |
|
disease | 0.100 | None | 0.981 | 105 | 0 | 1998 | 2020 | |||||||||
|
aquaporin 4 | 0.456 | 0.885 | 2.3E-03 |
|
disease | 0.100 | None | 0.970 | 66 | 0 | 2006 | 2020 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.100 | None | 0.981 | 54 | 0 | 1996 | 2020 | ||||||||
|
laminin subunit gamma 2 | 0.389 | 0.923 | 2.9E-12 |
|
disease | 0.100 | None | 1.000 | 43 | 0 | 2017 | 2020 | ||||||||
|
keratin 20 | 0.388 | 0.846 | 9.1E-11 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 2010 | 2020 | ||||||||
|
membrane spanning 4-domains A1 | 0.411 | 0.846 | 5.1E-05 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 2010 | 2020 | ||||||||
|
T cell receptor beta variable 20/OR9-2 (non-functional) | 0.403 | 0.923 |
|
disease | 0.100 | None | 0.917 | 36 | 0 | 1989 | 2019 | |||||||||
|
major histocompatibility complex, class II, DQ beta 1 | 0.407 | 0.885 | 8.9E-03 |
|
disease | 0.400 | None | 0.912 | 34 | 0 | 1991 | 2019 | ||||||||
|
neurofilament light | 0.488 | 0.769 |
|
disease | 0.100 | None | 0.968 | 31 | 0 | 2004 | 2020 | |||||||||
|
major histocompatibility complex, class II, DR beta 5 | 0.608 | 0.731 | 3.6E-07 |
|
disease | 0.100 | None | 0.967 | 30 | 0 | 1976 | 2019 | ||||||||
|
interferon stimulated exonuclease gene 20 | 0.414 | 0.846 | 2.9E-03 |
|
disease | 0.100 | None | 1.000 | 27 | 0 | 1994 | 2019 | ||||||||
|
interferon alpha 1 | 0.371 | 0.923 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1999 | 2019 | |||||||||
|
interferon alpha 13 | 0.374 | 0.923 |
|
disease | 0.100 | None | 1.000 | 26 | 0 | 1999 | 2019 | |||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.100 | None | 0.885 | 26 | 0 | 2001 | 2019 | ||||||||
|
major histocompatibility complex, class II, DP beta 1 | 0.453 | 0.923 | 5.3E-10 |
|
disease | 0.400 | None | 0.880 | 25 | 0 | 1990 | 2018 | ||||||||
|
endogenous retrovirus group W member 1, envelope | 0.505 | 0.692 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 2004 | 2019 | |||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.100 | None | 0.850 | 20 | 0 | 1998 | 2019 | ||||||||
|
membrane bound transcription factor peptidase, site 1 | 0.532 | 0.692 | 7.6E-09 |
|
disease | 0.100 | None | 1.000 | 20 | 0 | 2007 | 2020 | ||||||||
|
interleukin 7 | 0.464 | 0.808 | 0.93 |
|
disease | 0.400 | None | 0.947 | 19 | 0 | 2007 | 2018 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
disease | 0.100 | None | 0.947 | 19 | 0 | 2006 | 2019 | ||||||||
|
nuclear factor, erythroid 2 like 2 | 0.357 | 0.885 | 3.6E-03 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 2009 | 2020 | ||||||||
|
C-C motif chemokine ligand 5 | 0.403 | 0.885 | 1.8E-03 |
|
disease | 0.100 | None | 0.933 | 15 | 0 | 1997 | 2018 | ||||||||
|
crystallin alpha B | 0.515 | 0.731 | 2.2E-02 |
|
disease | 0.100 | None | 1.000 | 14 | 0 | 1996 | 2019 |